Johnson and Johnson Newswire

Johnson and Johnson Newswire

Comprehensive Real-Time News Feed for Johnson and Johnson.

Results 1 - 20 of 4,305 in Johnson and Johnson

  1. Blackhill Capital Inc. Has $24,113,000 Position in Johnson & JohnsonRead the original story w/Photo

    14 hrs ago | IntersportsWire

    Blackhill Capital Inc. raised its stake in shares of Johnson & Johnson by 1.4% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commission . The institutional investor owned 209,300 shares of the company's stock after buying an additional 2,800 shares during the period.

    Comment?

  2. Zelda: Breath of the Wild Is First AAA Game Developed by NintendoRead the original story

    18 hrs ago | The Oak Ridge Observer

    Breath of the Wild is Nintendo's attempt to merge the iconic Zelda formula with more modern open-world adventures, like Skyrim or The Witcher . Speaking of food, cooking plays a surprisingly large role in Breath of the Wild .

    Comment?

  3. Trader's Roundup: Johnson & JohnsonRead the original story

    18 hrs ago | The Oak Ridge Observer

    With the last stock price up 4.37% relative to the two hundred day average, compared with the Standard & Poor's 500 Index which has increased 0.05% over the same time period. Nwam LLC's holdings in Johnson & Johnson were worth $1,279,000 as of its most recent SEC filing.

    Comment?

  4. Scotland coach Vern Cotter reveals cunning plan for Wales Six Nations clashRead the original story

    18 hrs ago | The Oak Ridge Observer

    Losing to the ever-improving France is no disgrace, but for Scotland to really hammer home their message of improvement, they needed to take that match and simply have to win on Saturday against Wales. Coverage: Watch live on BBC One, BBC One HD, online, tablets, mobiles and BBC Sport app from 1400 GMT; listen on BBC Radio 5 Live; text commentary on BBC Sport website.

    Comment?

  5. Revenue Approximations Analysis: Diamond Offshore Drilling, Inc.Read the original story

    18 hrs ago | The Oak Ridge Observer

    According to Thomson Reuters, sell-side analysts are forecasting a harmony target price of $35.40 on company shares. At present, 16 analysts recommended Holding these shares while 3 recommended sell, according to FactSet data.

    Comment?

  6. The 2017 Academy Awards Cheatsheet 47:07Read the original story w/Photo

    19 hrs ago | The Oak Ridge Observer

    This year's Oscars will be awarded on February 26 at the Dolby Theatre in Hollywood, airing at 8.30 p.m. ET on ABC. Meryl Streep of Florence Foster Jenkins and Jeff Bridges of Hell or High Water are the oldest acting nominees, at 67. "Nocturnal Animals" was not a particularly well-received film, although I liked it, and I would be surprised if Michael Shannon won the award.

    Comment?

  7. Soulja Boy Clowns Chris Brown For Backing Out Of Their FightRead the original story w/Photo

    19 hrs ago | The Oak Ridge Observer

    The Grammy victor was ordered to stay 100 yards away from Karrueche Tran and not attempt to contact her after she wrote in court filings that Brown had repeatedly threatened her since December. In a sworn statement, Karrueche says she "told a few people that he was going to kill me", alleging that Chris told the people he was going to "take her out" and "shoot her" if they couldn't be together.

    Comment?

  8. BMC polls: Nitin Gadkari bats for BJP-Sena allianceRead the original story

    20 hrs ago | The Oak Ridge Observer

    He, however, added that the party has not taken a final call yet and that senior Maharashtra Congress leaders will travel to Delhi to discuss the Brihanmumbai Municipal Corporation results and the party's dismal performance in the state. While the Shiv Sena emerged on top with 84 seats, the BJP was a close second at 82 and, claiming the support of at least four independents, announced it would stake a claim to the key post of mayor.

    Comment?

  9. Johnson & Johnson May Already Have Its Remicade Replacement Well in HandRead the original story w/Photo

    Yesterday | The Motley Fool

    This drug being sold by J&J "definitely" has $9 billion in peak sales potential, according to Genmab's CEO. . Johnson & Johnson is often a staple holding for income seekers, conservative investors, and even value investors.

    Comment?

  10. A Dividend Portfolio Built From The World's Best Dividend ETFsRead the original story w/Photo

    Friday | Seeking Alpha

    While my work here on Seeking Alpha primarily revolves around ETFs, I am well aware that many investors prefer to build their portfolio primarily or exclusively using individual stocks. In particular, when it comes to dividend investing, might there be an opportunity to unite the two points of view, to harness the power of ETFs to select individual stocks? In this article, I will attempt to do just that.

    Comment?

  11. Upcoming Events: J&J And NeuroDerm Put New Delivery Routes To The TestRead the original story w/Photo

    Friday | Seeking Alpha

    Welcome to your weekly digest of approaching regulatory and clinical readouts. In the coming months phase III data are expected from Johnson & Johnson , an analogue of ketamine whose selling point could be its nasal administration; however, hallucinatory side effects could put a damper on its commercial prospects.

    Comment?

  12. Remarks by President Trump at Signing of Executive Order on Regulatory ReformRead the original story w/Photo

    Friday | The White House

    ... are Ken Fisher and Ken Frazier, Chairman and President, CEO of Merck. Alex Gorsky, Chairman, CEO of Johnson and Johnson. Marillyn Hewson -- and she has been very tough to deal with but that's okay -- (laughter) -- she's a very tough negotiator, ...

    Comment?

  13. Johnson & Johnson Therapeutic and Drug Pipeline Review H2Read the original story

    Friday | World News Report

    PUNE, INDIA, February 24, 2017 / EINPresswire.com / -- Summary The report provides comprehensive information on the therapeutics under development by Johnson & Johnson , complete with analysis by stage of development, drug target, mechanism of action , route of administration and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history and the dormant and discontinued projects.

    Comment?

  14. Trump signs executive order on regulatory reformRead the original story w/Photo

    Friday | UPI

    He signed the order in the White House with business executives who advise him on policy and meet with him regularly. Trump said "excessive regulation is killing jobs" and "driving companies out of our country like never before.

    Comment?

  15. ValueAct Capital Is Going Risk-Off. Right Or Wrong?Read the original story w/Photo

    Friday | Seeking Alpha

    ValueAct Capital CEO Jeffrey Ubben told Reuters ValueAct is taking money out of the market. Cash is racking up and they are almost 20% in cash now.

    Comment?

  16. ACWV, DXJH: Big ETF OutflowsRead the original story

    Friday | MarketNewsVideo

    Looking at units outstanding versus one week prior within the universe of ETFs covered at ETF Channel, the biggest outflow was seen in the iShares Edge MSCI Min Vol Global ETF , where 3,300,000 units were destroyed, or a 7.9% decrease week over week. Among the largest underlying components of ACWV, in morning trading today Johnson & Johnson is up about 1%, and Automatic Data Processing is higher by about 0.2%.

    Comment?

  17. Dr. Guislain Museum and Janssen Seek Nominations for 2017 "Breaking the Chains of Stigma" AwardRead the original story

    Thursday Feb 23 | KTMF

    The Award honors an individual, project or organization that has made a remarkable contribution to reduce stigma associated with mental illness. Nominations from people and organizations worldwide can be submitted at www.drguislainaward.org until 16 April, 2017.

    Comment?

  18. Dow Movers: CAT, NKERead the original story

    Friday | MarketNewsVideo

    In early trading on Friday, shares of Nike topped the list of the day's best performing Dow Jones Industrial Average components, trading up 1.6%. Year to date, Nike registers a 14.7% gain.

    Comment?

  19. Cryptococcosis Market Research Reports Offers Key Insights 2016 - 2024Read the original story w/Photo

    Friday | SBWire

    Global Cryptococcosis Market: Snapshot One of the key factors driving the global cryptococcosis market is the increasing incidence of cryptococcosis infections across the world. The number of patients suffering from cryptococcosis has been found to be on the rise at a faster rate than previously thought.

    Comment?

  20. Synergy: 3 Scenarios, 1 ChoiceRead the original story w/Photo

    Friday | Seeking Alpha

    Synergy has a recently FDA approved product to be used by patients with chronic idiopathic constipation . It may soon offer an sNDA for irritable bowel syndrome, constipation .

    Comment?